PA
ROIV icon

Perceptive Advisors’s Roivant Sciences ROIV Stock Holding History

Perceptive Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230M Buy
8,285,461
+300,000
+4% +$7.71M 4.48% 4
2025
Q4 		$173M Buy
7,985,461
+617,000
+8% +$12.2M 3.09% 6
2025
Q3 		$111M Buy
7,368,461
+4,036,996
+121% +$50M 3.22% 8
2025
Q2 		$37.5M Buy
+3,331,465
New +$36.1M 1.39% 18
2024
Q4 		– Sell
-847,745
Closed -$9.78M – 115
2024
Q3 		$9.78M Buy
+847,745
New +$9.65M 0.21% 71
2023
Q4 		– Sell
-3,819,456
Closed -$44.6M – 113
2023
Q3 		$44.6M Buy
3,819,456
+687,720
+22% +$7.77M 1.49% 21
2023
Q2 		$31.6M Buy
3,131,736
+439,600
+16% +$3.93M 0.91% 34
2023
Q1 		$19.9M Buy
2,692,136
+710,566
+36% +$5.85M 0.59% 46
2022
Q4 		$15.8M Buy
+1,981,570
New +$11M 0.44% 48

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Perceptive Advisors's ROIV Position: Q1 2026 in Review

Perceptive Advisors increased its Roivant Sciences (ROIV) stake by 3.8% in Q1 2026, buying an estimated $7.71M and bringing the position to 8,285,461 shares worth $230M. The position accounts for 4.48% of the portfolio, ranked #4.

Perceptive Advisors first reported a position in ROIV in Q4 2022 and has held it in 9 quarters since. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Perceptive Advisors held 8,285,461 shares of Roivant Sciences worth $230M as of Q1 2026.
  • Perceptive Advisors bought 300,000 Roivant Sciences shares in Q1 2026, an estimated $7.71M.
  • Roivant Sciences made up 4.48% of Perceptive Advisors's portfolio in Q1 2026, its #4 holding.
  • Perceptive Advisors first reported a position in Roivant Sciences in Q4 2022 and has held it in 9 quarters since.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.